Description de l'entreprise
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Conseil d'administration & Conseil de surveillance
| PDG |
| Paul Hudson |
| Conseil d'administration |
| Jean-Baptiste Chasseloup de Chatillon, Bill Sibold, Brendan O’Callaghan, Julie Van Ongevalle, Natalie Bickford, Olivier Charmeil, Roy Papatheodorou, Thomas Triomphe |
| Conseil de surveillance |
| Frédéric Oudéa, Barbara Lavernos, Ceng-Yann Tran, Christophe Babule, Diane Souza, Fabienne Lecorvaisier, Gilles Schnepp, Lise Kingo, Patrick Kron, Paul Hudson, Rachel Duan, Thomas Südhof, Wolfgang Laux, Carole Ferrand, Emile Voest, Antoine Yver, Frédéric Oudéa |
Données de l'entreprise
| Nom: |
Sanofi S.A. |
| Adresse: |
54, Rue La Boétie,F-75008 Paris |
| Téléphone: |
+33-1-53-77-40-00 |
| Fax: |
+33-1-53-77-43-03 |
| Courriel: |
-
|
| Internet: |
https://www.sanofi.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
88.70% |
| IPO date: |
- |
